Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Di Perri

Showing results (61-70 of 438) with videos related to

Pageof 44
Sort By:
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|October 28, 2005
[Ertapenem. A new carbapenem in a single dose for community acquired infection]Giovanni Di Perri, Olivia Bargiacchi, Silvia Garazzino, et al.
Turkish Journal of Anaesthesiology and Reanimation|January 7, 2017
Antifungal Treatment Strategies in the ICU: Beyond Meta-analysisFrancesco Giuseppe De Rosa, Silvia Corcione, Giorgia Montrucchio, et al.
Microorganisms|September 28, 2024
Central Nervous System Disorders with Auto-Antibodies in People Living with HIVGiacomo Stroffolini, Cristiana Atzori, Daniele Imperiale, et al.
Future Microbiology|February 18, 2015
Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: a critical agendaFrancesco G De Rosa, Silvia Corcione, Rossana Cavallo, et al.
Microorganisms|July 27, 2022
Concurrent and Subsequent Co-Infections of <i>Clostridioides difficile</i> Colitis in the Era of Gut Microbiota and Expanding Treatment OptionsMattia Trunfio, Silvia Scabini, Walter Rugge, et al.
AIDS Research and Human Retroviruses|July 8, 2014
Disappearance of renal stones in an HIV-1-infected patient after reduction of atazanavir doseMassimiliano Lanzafame, Stefano Bonora, Emanuela Lattuada, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2013
Elimination half-life may explain the relative efficacy of boceprevir and telaprevir in the treatment of hepatitis C virus genotype 1Andrea Calcagno, Lucio Boglione, Francesco Giuseppe De Rosa, et al.
Archives of Virology|June 11, 2015
Role of IL28B genotyping in patients with hepatitis C virus-associated mixed cryoglobulinemia and response to PEG-IFN and ribavirin treatmentLucio Boglione, Jessica Cusato, Sarah Allegra, et al.
AIDS (London, England)|March 18, 2010
Raltegravir penetration in the cerebrospinal fluid of HIV-positive patientsAndrea Calcagno, Stefano Bonora, Roberto Bertucci, et al.
Archives of Virology|February 13, 2021
Serological and virological response in patients with hepatitis B virus genotype E treated with entecavir or tenofovir: a prospective studyLucio Boglione, Ilaria De Benedetto, Tommaso Lupia, et al.
Pageof 44

Showing results (61-70 of 438) with videos related to

Sort By:
Pageof 44
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|October 28, 2005
[Ertapenem. A new carbapenem in a single dose for community acquired infection]Giovanni Di Perri, Olivia Bargiacchi, Silvia Garazzino, et al.
Turkish Journal of Anaesthesiology and Reanimation|January 7, 2017
Antifungal Treatment Strategies in the ICU: Beyond Meta-analysisFrancesco Giuseppe De Rosa, Silvia Corcione, Giorgia Montrucchio, et al.
Microorganisms|September 28, 2024
Central Nervous System Disorders with Auto-Antibodies in People Living with HIVGiacomo Stroffolini, Cristiana Atzori, Daniele Imperiale, et al.
Future Microbiology|February 18, 2015
Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: a critical agendaFrancesco G De Rosa, Silvia Corcione, Rossana Cavallo, et al.
Microorganisms|July 27, 2022
Concurrent and Subsequent Co-Infections of <i>Clostridioides difficile</i> Colitis in the Era of Gut Microbiota and Expanding Treatment OptionsMattia Trunfio, Silvia Scabini, Walter Rugge, et al.
AIDS Research and Human Retroviruses|July 8, 2014
Disappearance of renal stones in an HIV-1-infected patient after reduction of atazanavir doseMassimiliano Lanzafame, Stefano Bonora, Emanuela Lattuada, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2013
Elimination half-life may explain the relative efficacy of boceprevir and telaprevir in the treatment of hepatitis C virus genotype 1Andrea Calcagno, Lucio Boglione, Francesco Giuseppe De Rosa, et al.
Archives of Virology|June 11, 2015
Role of IL28B genotyping in patients with hepatitis C virus-associated mixed cryoglobulinemia and response to PEG-IFN and ribavirin treatmentLucio Boglione, Jessica Cusato, Sarah Allegra, et al.
AIDS (London, England)|March 18, 2010
Raltegravir penetration in the cerebrospinal fluid of HIV-positive patientsAndrea Calcagno, Stefano Bonora, Roberto Bertucci, et al.
Archives of Virology|February 13, 2021
Serological and virological response in patients with hepatitis B virus genotype E treated with entecavir or tenofovir: a prospective studyLucio Boglione, Ilaria De Benedetto, Tommaso Lupia, et al.
Pageof 44